Under normal conditions, ABL kinase activity is tightly regulated through various mechanisms, including phosphorylation, protein-protein interactions, and subcellular localization. However, in cancer, these regulatory mechanisms are often disrupted, leading to the pathologically increased activity of ABL kinase.
